Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA: Dräger with solid business performance in the first quarter of 2024

Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2024: Net sales and earnings below the strong prior-year quarter – Annual forecast confirmed

Drägerwerk AG & Co. KGaA: Bekanntmachung der Einberufung zur Hauptversammlung am 08.05.2024 in Lübeck mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend

Drägerwerk AG & Co. KGaA: Preliminary figures 2023: Net sales and earnings significantly above prior year – Dividend increase – Forecast 2024

Drägerwerk AG & Co. KGaA: Annual forecast raised again

Drägerwerk AG & Co. KGaA: Annual forecast raised again

Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052

Drägerwerk AG & Co. KGaA: Anton Schrofner, Purchase under the employee participation program: The terms and conditions of the employee participation program stipulate that, if the price of the …

Drägerwerk AG & Co. KGaA: Gert-Hartwig Lescow, Purchase under the employee participation program: The terms and conditions of the employee participation program stipulate that, if the price of …

Drägerwerk AG & Co. KGaA: Stefan Dräger, Purchase under the employee participation program: The terms and conditions of the employee participation program stipulate that, if the price of the …

Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and earnings in the first nine months of 2023

Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings – full-year forecast raised

Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission

Drägerwerk AG & Co. KGaA: Dräger with significant increase in net sales and earnings in the first half of 2023

Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed

Drägerwerk AG & Co. KGaA: Correction of a prior-year figure in the ad-hoc notification dated April 17, 2023. All other content unchanged.

Drägerwerk AG & Co. KGaA: Dräger’s Annual General Meeting approves stable dividend for fiscal year 2022

Drägerwerk AG & Co. KGaA: Dräger with strong net sales growth and positive earnings in the first quarter of 2023

Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2023: Strong net sales growth and positive EBIT – forecast for 2023 confirmed

Drägerwerk AG & Co. KGaA: Bekanntmachung der Einberufung zur Hauptversammlung am 05.05.2023 in Lübeck mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

Drägerwerk AG & Co. KGaA: Dräger expects return to profitable growth in 2023

Drägerwerk AG & Co. KGaA: Preliminary figures 2022: net sales and earnings significantly below prior year despite continued high order backlog – forecast 2023: return to growth and profitability

Drägerwerk AG & Co. KGaA: Dräger redeems last participation certificates – streamlining of capital structure completed

Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052

Drägerwerk AG & Co. KGaA: Gert-Hartwig Lescow, Purchase under an employee participation program: The terms and conditions of the employee participation program stipulate that, if the price of …

Drägerwerk AG & Co. KGaA: Stefan Dräger, Purchase under the employee participation program: The terms and conditions of the employee participation program stipulate that, if the price of the …

Drägerwerk AG & Co. KGaA: Dräger expects faster sales recognition in the fourth quarter of 2022